1. Home
  2. SNGX vs SONM Comparison

SNGX vs SONM Comparison

Compare SNGX & SONM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • SONM
  • Stock Information
  • Founded
  • SNGX 1987
  • SONM 1999
  • Country
  • SNGX United States
  • SONM United States
  • Employees
  • SNGX N/A
  • SONM N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • SONM Telecommunications Equipment
  • Sector
  • SNGX Health Care
  • SONM Telecommunications
  • Exchange
  • SNGX Nasdaq
  • SONM Nasdaq
  • Market Cap
  • SNGX 10.1M
  • SONM 12.1M
  • IPO Year
  • SNGX 1987
  • SONM 2019
  • Fundamental
  • Price
  • SNGX $2.92
  • SONM $0.68
  • Analyst Decision
  • SNGX Strong Buy
  • SONM
  • Analyst Count
  • SNGX 1
  • SONM 0
  • Target Price
  • SNGX $6.00
  • SONM N/A
  • AVG Volume (30 Days)
  • SNGX 10.0M
  • SONM 234.7K
  • Earning Date
  • SNGX 11-07-2025
  • SONM 11-12-2025
  • Dividend Yield
  • SNGX N/A
  • SONM N/A
  • EPS Growth
  • SNGX N/A
  • SONM N/A
  • EPS
  • SNGX N/A
  • SONM N/A
  • Revenue
  • SNGX N/A
  • SONM $57,917,000.00
  • Revenue This Year
  • SNGX N/A
  • SONM $127.68
  • Revenue Next Year
  • SNGX N/A
  • SONM N/A
  • P/E Ratio
  • SNGX N/A
  • SONM N/A
  • Revenue Growth
  • SNGX N/A
  • SONM N/A
  • 52 Week Low
  • SNGX $1.09
  • SONM $0.52
  • 52 Week High
  • SNGX $6.23
  • SONM $6.38
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 51.64
  • SONM 61.11
  • Support Level
  • SNGX $2.58
  • SONM $0.55
  • Resistance Level
  • SNGX $3.11
  • SONM $0.61
  • Average True Range (ATR)
  • SNGX 0.22
  • SONM 0.04
  • MACD
  • SNGX -0.09
  • SONM 0.02
  • Stochastic Oscillator
  • SNGX 43.59
  • SONM 88.75

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

Share on Social Networks: